Tag

Eli Lilly and Co. on Thursday reported better-than-expected second-quarter profit on a boost from its recently acquired animal health unit and raised its outlook. Revenue guidance was revised to $19.7 billion to $20.0 billion, up from $19.5 billion to $20.0 billion. Eight...

Innovating care in a tough-to-treat indicationIn its presentation on Wednesday, the company will unveil data showing whether or not solanezumab can halt Alzheimer’s disease progression in patients suffering from a mild form of the disease. Eric Siemers, medical director for...